In addition, it should be noted that the B-RSTTM was developed and validated as a tool to identify individuals at increased risk for BRCA1/2 mutations and it does not incorporate other breast cancer risk factors (e.g., smoking, alcohol consumption, age at menarche, age at first live birth of child). This evidence concerns the gene BRCA1 and breast carcinoma.